EGFR and non-small cell lung carcinoma: Marcoux et al., in a series with 58 NSCLC patients with EGFR mutations, found that the median time to transformation, median overall survival after diagnosis, and median survival after SCLC transformation were 17.8, 31.5, and 10.9 months, respectively [15].